Navigation Links
ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor [Human]) in European Union
Date:3/18/2011

/p>

The most common adverse reactions observed have been upper respiratory infection, sinusitis, rash and headache. No drug-related serious adverse events (SAEs) have been observed in clinical trials.

Cinryze is for intravenous use only. Per the U.S. label, a dose of 1000 Units of Cinryze can be administered every 3 or 4 days for routine prophylaxis against angioedema attacks in HAE patients. Cinryze is administered at an injection rate of 1 mL per minute.

About Hereditary Angioedema (HAE)

HAE is a rare, severely debilitating, life-threatening genetic disorder caused by a deficiency of C1 inhibitor, a human plasma protein. This condition is the result of a defect in the gene controlling the synthesis of C1 inhibitor. C1 inhibitor maintains the natural regulation of the contact, complement, and fibrinolytic systems, that when left unregulated, can initiate or perpetuate an attack by consuming the already low levels of endogenous C1 inhibitor in HAE patients. Patients with C1 inhibitor deficiency experience recurrent, unpredictable, debilitating, and potentially life threatening attacks of inflammation affecting the larynx, abdomen, face, extremities and urogenital tract. Patients with HAE experience approximately 20 to 100 days of incapacitation per year. There are estimated to be at least 6,500 people with HAE in the United States and approximately similar demographics in the European Union.

For more information on HAE, visit the U.S. HAE Association's website at: www.haea.org or the HAEi (International Patient Organization for C1 Inhibitor Deficiencies) at www.haei.org.

About ViroPharma Incorporated

ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing innovative products for physician specialists to enable the support of patients with serious diseases for which there is
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. ViroPharma to Present at the Natixis Bleichroeder Conference
3. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
5. ViroPharma Announces Discontinuation of HCV-796 Development
6. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
7. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
8. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
9. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
10. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
11. ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... 2014 Breast cancer will interrupt life ... who get a new diagnosis. The Commission for ... case managers to help those diagnosed with advanced ... physical, emotional and financial decisions that come with ... cost via the Commission,s online knowledge resource, the ...
(Date:11/18/2014)... 18, 2014  TransCelerate BioPharma Inc. ("TransCelerate") ... manuscript on Risk-Based Monitoring (RBM), " Evaluating ... Measure in Clinical Trials ," in the ... Regulatory Science  (TIRS) journal. Developed by TransCelerate,s ... the manuscript examines the value of Source ...
(Date:11/18/2014)... , Nov. 18, 2014   Rio Grande ... with University of Texas Health Science Center at ... Brownsville , has selected Wellcentive,s suite of ... providers in a four-county area to partner with hospitals ... health of their Medicaid and uninsured patient populations, initially ...
Breaking Medicine Technology:New Breast Cancer Resources: Commission For Case Manager Certification Adds Specialty Tools to Case Management Body of Knowledge Online Learning Center 2TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 2TransCelerate BioPharma Inc. Publishes Recommendation on Use of Source Data Verification in Risk-Based Monitoring, Releases Third Update on Initiative Progress 3Rio Grande Valley Health Information Exchange and University of Texas Health Science Center Select Wellcentive to Manage Health and Cost of Medicaid and Uninsured Populations 2Rio Grande Valley Health Information Exchange and University of Texas Health Science Center Select Wellcentive to Manage Health and Cost of Medicaid and Uninsured Populations 3Rio Grande Valley Health Information Exchange and University of Texas Health Science Center Select Wellcentive to Manage Health and Cost of Medicaid and Uninsured Populations 4
... N.J., April 25, 2012 Watson Pharmaceuticals, Inc. (NYSE: ... Watson has entered into a definitive agreement to acquire privately ... a result of this acquisition, Watson will become the third ... of approximately $8 billion. Actavis, which as ...
... STAAR Surgical Company (NASDAQ: STAA ) today announced that ... 30, 2012 on Wednesday, May 2, 2012 after ... call and webcast on Wednesday, May 2, 2012 at 4:30 ... to discuss the Company,s first quarter 2012 results and recent corporate developments. ...
Cached Medicine Technology:Watson to Acquire Actavis Group for EUR4.25 Billion 2Watson to Acquire Actavis Group for EUR4.25 Billion 3Watson to Acquire Actavis Group for EUR4.25 Billion 4Watson to Acquire Actavis Group for EUR4.25 Billion 5Watson to Acquire Actavis Group for EUR4.25 Billion 6Watson to Acquire Actavis Group for EUR4.25 Billion 7Watson to Acquire Actavis Group for EUR4.25 Billion 8Watson to Acquire Actavis Group for EUR4.25 Billion 9STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast 2
(Date:11/21/2014)... MLF Biotech, Inc. has developed a ... for Pets helps maintain digestive health and can assist ... flora after it experiences a period of stress, dietary ... Pets is a proprietary blend of pure probiotics with ... bacteria strains that are safe and effective for both ...
(Date:11/21/2014)... November 21, 2014 The typical Thanksgiving ... calorie dishes, plenty of gravy and a myriad of ... the best time of year to begin losing weight? ... has uncovered the secret to losing unhealthy, embarrassing and ... holiday recipes. , The insight to Diet Doc’s calorie ...
(Date:11/21/2014)... Florida (PRWEB) November 21, 2014 TruDenta, ... chronic headaches and other jaw-related symptoms, has ... seeking relief from chronic head pain, neck pain, TMJ ... , “This year we have seen a 52% increase ... Our network of over 300 doctors and their teams ...
(Date:11/21/2014)... November 21, 2014 Even with years of ... to learn and room for growth, participating in two recent ... State Farm’s National Convention, a networking event with the leaders ... country, bringing back the latest and greatest in insurance news ... spotted Kirk and his team (Stacy, Anthony, Reina and Jacob) ...
(Date:11/21/2014)... TX (PRWEB) November 21, 2014 ... facility at 7am today. The new facility is located ... open 24-7. , “We are pleased to join ... highest quality emergency medical care here,” said Dr. Siddiqi, ... , To celebrate the opening, First Choice ...
Breaking Medicine News(10 mins):Health News:MLF Biotech Introduces Liv-Pro Probiotics for Pets 2Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 2Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 3Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 4Health News:National Rise In Patients Seeking Headache Relief 2Health News:Kirk Martin Insurance Agency Goes Local and National with State Farm 2Health News:First Choice Emergency Room Opens New Facility in Friendswood, Texas 2
... Being satisfied with your life can be good for your ... included almost 8,000 British civil servants, average age 49, who ... lives: romantic relationships, leisure activities, job, family, sex, standard of ... about six years, higher levels of overall life satisfaction were ...
... improvements in surgical care in early-stage lung cancer have ... according to a population-based study presented at the 14th ... the International Association for the Study of Lung Cancer ... lung cancer (NSCLC) patients increased by nearly 8 months ...
... diabetes, arthritis, chronic respiratory disorders and cancer represent the ... affect all age groups. The cost of treating these ... under-appreciated cause of poverty. In BioMed Central,s ... group of scientists and medical doctors have proposed an ...
... , TUESDAY, July 5 (HealthDay News) -- The timing and ... best customized for each woman, based on such factors as ... for all women based on age alone is not the ... Schousboe, medical director of research at Park Nicollet Health Services ...
... Researchers have identified when an important milestone in infants, ... situations. In a series of studies, the researchers ... in a different circumstance, but 16-month-olds could do so. ... begin learning how to learn," said Julie Hupp, lead ...
... -- ,A new study finds that painkillers widely used ... of atrial fibrillation, a heart rhythm disorder connected with ... Previous research has linked non-steroidal anti-inflammatory drugs ... to an increased risk for heart attacks and strokes, ...
Cached Medicine News:Health News:Elderly Dutch lung patients' survival improved by new treatment options between 2003-2009 2Health News:Mammogram Schedule Should Be Customized, Study Finds 2Health News:Mammogram Schedule Should Be Customized, Study Finds 3Health News:Infants learn to transfer knowledge by 16 months, study finds 2Health News:Infants learn to transfer knowledge by 16 months, study finds 3Health News:Painkillers May Raise Risk of Dangerous Heart Flutter 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: